Literature DB >> 26282212

Prostate cancer: Novel xenografts in mice--a new wave of preclinical models.

Gail P Risbridger1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26282212     DOI： 10.1038/nrurol.2015.198

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  7 in total

1.  Formation of human prostate tissue from embryonic stem cells.

Authors:  Renea A Taylor; Prue A Cowin; Gerald R Cunha; Martin Pera; Alan O Trounson; John Pedersen; Gail P Risbridger
Journal:  Nat Methods       Date:  2006-03       Impact factor: 28.547

Review 2.  Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.

Authors:  Kathryn E Ware; Mariano A Garcia-Blanco; Andrew J Armstrong; Scott M Dehm
Journal:  Endocr Relat Cancer       Date:  2014-05-23       Impact factor: 5.678

3.  Abiraterone and increased survival in metastatic prostate cancer.

Authors:  Johann S de Bono; Christopher J Logothetis; Arturo Molina; Karim Fizazi; Scott North; Luis Chu; Kim N Chi; Robert J Jones; Oscar B Goodman; Fred Saad; John N Staffurth; Paul Mainwaring; Stephen Harland; Thomas W Flaig; Thomas E Hutson; Tina Cheng; Helen Patterson; John D Hainsworth; Charles J Ryan; Cora N Sternberg; Susan L Ellard; Aude Fléchon; Mansoor Saleh; Mark Scholz; Eleni Efstathiou; Andrea Zivi; Diletta Bianchini; Yohann Loriot; Nicole Chieffo; Thian Kheoh; Christopher M Haqq; Howard I Scher
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

4.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Authors:  Philip W Kantoff; Celestia S Higano; Neal D Shore; E Roy Berger; Eric J Small; David F Penson; Charles H Redfern; Anna C Ferrari; Robert Dreicer; Robert B Sims; Yi Xu; Mark W Frohlich; Paul F Schellhammer
Journal:  N Engl J Med       Date:  2010-07-29       Impact factor: 91.245

5.  Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.

Authors:  Matthias Saar; Christina Körbel; Johannes Linxweiler; Volker Jung; Jörn Kamradt; Andrea Hasenfus; Michael Stöckle; Gerhard Unteregger; Michael D Menger
Journal:  Prostate       Date:  2015-06-12       Impact factor: 4.104

6.  Enzalutamide in metastatic prostate cancer before chemotherapy.

Authors:  Tomasz M Beer; Andrew J Armstrong; Dana E Rathkopf; Yohann Loriot; Cora N Sternberg; Celestia S Higano; Peter Iversen; Suman Bhattacharya; Joan Carles; Simon Chowdhury; Ian D Davis; Johann S de Bono; Christopher P Evans; Karim Fizazi; Anthony M Joshua; Choung-Soo Kim; Go Kimura; Paul Mainwaring; Harry Mansbach; Kurt Miller; Sarah B Noonberg; Frank Perabo; De Phung; Fred Saad; Howard I Scher; Mary-Ellen Taplin; Peter M Venner; Bertrand Tombal
Journal:  N Engl J Med       Date:  2014-06-01       Impact factor: 91.245

7.  A preclinical xenograft model of prostate cancer using human tumors.

Authors:  Mitchell G Lawrence; Renea A Taylor; Roxanne Toivanen; John Pedersen; Sam Norden; David W Pook; Mark Frydenberg; Melissa M Papargiris; Birunthi Niranjan; Michelle G Richards; Hong Wang; Anne T Collins; Norman J Maitland; Gail P Risbridger
Journal:  Nat Protoc       Date:  2013-04-04       Impact factor: 13.491
  7 in total
  2 in total

Review 1.  Patient-Derived Prostate Cancer: from Basic Science to the Clinic.

Authors:  Gail P Risbridger; Renea A Taylor
Journal:  Horm Cancer       Date:  2016-05-13       Impact factor: 3.869

Review 2.  [Prostate and breast cancer: similarities and differences].

Authors:  Jennifer Kranz; Marco Hoffmann; Katja Krauß; Elmar Stickeler; Matthias Saar
Journal:  Urologie       Date:  2022-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.